15 min listen
NEJM Interview: Dr. Jerry Avorn on a new estimate of the cost of bringing a drug to market.
FromNEJM Interviews
NEJM Interview: Dr. Jerry Avorn on a new estimate of the cost of bringing a drug to market.
FromNEJM Interviews
ratings:
Length:
12 minutes
Released:
May 13, 2015
Format:
Podcast episode
Description
Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Avorn. The $2.6 Billion Pill - Methodologic and Policy Considerations. N Engl J Med 2015;372:1877-9.
Released:
May 13, 2015
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Dr. Jerry Avorn on the evolving approach to drug safety in the United States by NEJM Interviews